News

The results were seen in patients who had a recent manic or mixed episode and were then stabilized with the medication for at least six weeks. Abilify is

Uterine fibroids affects roughly half of all women aged 35 to 49. The non-cancerous tumors cause iron-deficiency anemia due to excessive menstrual bleeding. “With no approved treatment for

Specific patient populations include elderly patients who have previously untreated disease or adult patients who have relapsed or refractory disease. Key objectives of the study will be to

The existing agreement between the two companies was signed in 2003. The new expanded agreement, extended till 2010, offers additional opportunities for collaboration, and substantially increases the number

Myocardial ischemia is a condition where there is insufficient blood flow within the heart muscle. Generx represents a new therapeutic class of biologics designed to promote angiogenesis, a

Summit is co-developing Hextend for the Japanese market with Maruishi Pharmaceutical and both Maruishi and Summit have the right to co-market Hextend if regulatory approval is obtained. Summit

The development of Sparlon for attention deficit disorder has ceased but the FDA might delay its labeling decision concerning Nuvigil as it is a single-isomer formulation of modafinil,

The studies, which were performed in collaboration with the Karolinska Institute in Sweden, suggest that AV-101 may have therapeutic potential for treating the symptoms of Parkinson’s disease and

Iloperidone demonstrated statistically significant improvement compared to placebo on the Positive and Negative Symptom Scale (PANSS), the trial’s primary endpoint. Additionally, iloperidone achieved significant efficacy on the positive